(RTTNews) - Merck & Co Inc. (MRK) announced that KEYTRUDA (pembrolizumab) plus Trodelvy (sacituzumab govitecan-hziy) reduced the risk of disease progression or death by 35% compared to KEYTRUDA plus c ...

[Triple-negative breast cancer (TNBC) - closeup view 3d illustration] Nemes Laszlo/iStock via Getty Images Gilead Sciences (NASDAQ:GILD [https://seekingalpha.com/symbol/GILD]) announced Saturday that ...

Experts highlight the increase of hypertension diagnosis in young adults. Know what all habits help you reduce the risks.

CHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line ...

A man has been arrested following reports that a car collided with several pedestrians in Leicester city centre in the early ...

Here are all the highlights of Winterthur's biggest offering of the year, one of Delaware's most anticipated seasonal events. Point-to-Point at Winterthur is best known for its heart-pounding ...

Madden and Carabasi applied a similar approach on now defunct sibling strategy Delaware Mid Cap Value. That strategy struggled to add value versus peers and the Russell Midcap Value Index over the ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.